592 related articles for article (PubMed ID: 15820077)
21. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
Alkuwari E; Auger M
Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome.
Iguchi C; Nio Y; Itakura M
J Surg Oncol; 2003 Jun; 83(2):85-93. PubMed ID: 12772201
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the tracing effect of carbon nanoparticle and carbon nanoparticle-epirubicin suspension in axillary lymph node dissection for breast cancer treatment.
Du J; Zhang Y; Ming J; Liu J; Zhong L; Liang Q; Fan L; Jiang J
World J Surg Oncol; 2016 Jun; 14(1):164. PubMed ID: 27335011
[TBL] [Abstract][Full Text] [Related]
27. Clinical importance of preoperative detection of the apical lymph node metastasis in patients with breast carcinoma.
Güven HE; Bulak H; Turanli S; Oral S
Singapore Med J; 2007 Jan; 48(1):31-3. PubMed ID: 17245513
[TBL] [Abstract][Full Text] [Related]
28. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH
Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328
[TBL] [Abstract][Full Text] [Related]
29. Number of lymph nodes identified at axillary dissection: effect of neoadjuvant chemotherapy and other factors.
Boughey JC; Donohue JH; Jakub JW; Lohse CM; Degnim AC
Cancer; 2010 Jul; 116(14):3322-9. PubMed ID: 20564124
[TBL] [Abstract][Full Text] [Related]
30. [A case regarded as an occult breast cancer treated without mastectomy].
Kawashima T; Miyazawa Y; Sakata H; Matsubara H; Ryu M; Ochiai T
Gan To Kagaku Ryoho; 2005 Jun; 32(6):825-8. PubMed ID: 15984524
[TBL] [Abstract][Full Text] [Related]
31. Rationale of lymph node dissection for breast cancer--from the viewpoint of analysis of axillary lymphatic flow using activated carbon particle CH40.
Sawai K; Hagiwara A; Shimotsuma M; Sakakibara T; Imanishi T; Takemoto Y; Takahashi T
Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():30-5. PubMed ID: 8702308
[TBL] [Abstract][Full Text] [Related]
32. Quantitative molecular diagnosis of axillary drainage fluid for prediction of locoregional failure in patients with one to three positive axillary nodes after mastectomy without adjuvant radiotherapy.
Zhang Y; Ma QY; Dang CX; Moureau-Zabotto M; Chen WK
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):505-11. PubMed ID: 16257133
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2009 Jul; 16(7):1946-51. PubMed ID: 19408057
[TBL] [Abstract][Full Text] [Related]
34. Intramammary lymph nodes and breast cancer: a marker for disease severity, or just another lymph node?
Guth AA; Mercado C; Roses DF; Hiotis K; Skinner K; Diflo T; Cangiarella J
Am J Surg; 2006 Oct; 192(4):502-5. PubMed ID: 16978960
[TBL] [Abstract][Full Text] [Related]
35. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
[TBL] [Abstract][Full Text] [Related]
36. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
Goyal A; Newcombe RG; Chhabra A; Mansel RE
Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
[TBL] [Abstract][Full Text] [Related]
37. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy.
Newman EA; Cimmino VM; Sabel MS; Diehl KM; Frey KA; Chang AE; Newman LA
Ann Surg Oncol; 2006 Jan; 13(1):52-7. PubMed ID: 16372155
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy in invasive breast cancer results in a lower axillary lymph node count.
Bélanger J; Soucy G; Sidéris L; Leblanc G; Drolet P; Mitchell A; Leclerc YE; Beaudet J; Dufresne MP; Dubé P
J Am Coll Surg; 2008 Apr; 206(4):704-8. PubMed ID: 18387477
[TBL] [Abstract][Full Text] [Related]
39. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
40. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]